Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to efficiently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.
Domain
enliventherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$230.0M
Founded
2018
Tech Stack (6 technologies)
Frequently Asked Questions
What technologies does Enliven Therapeutics use?+
Enliven Therapeutics uses 6 technologies including Google Tag Manager, CookieYes, jQuery.
What industry is Enliven Therapeutics in?+
Enliven Therapeutics operates in the Biotechnology industry.
Where is Enliven Therapeutics based?+
Enliven Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026